Fluoroscopy and Mobile C-Arms Market Size, Share & Trends Analysis Report By Device Type (Fluoroscopy Systems, Mobile C-Arms), By Application (Orthopedics, Cardiovascular, Gastrointestinal, Pain Management & Trauma, Urology, Neurology, Others), By End-User (Hospital & Clinics, Diagnostic Centers, Research & Academic Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Fluoroscopy and Mobile C-Arms Market Size

The global fluoroscopy and mobile C-arms market size was valued at USD 4.53 billion in 2024 and is projected to grow from USD 4.75 billion in 2025 to reach USD 6.50 billion by 2033, exhibiting a CAGR of 4.01% during the forecast period (2025-2033).

Fluoroscopy is a dynamic imaging technique that provides real-time X-ray visualization of internal structures, enabling physicians to monitor movement and guide medical procedures with precision. It is widely utilized in diagnostics and interventional treatments, including catheter placements, orthopedic surgeries, and gastrointestinal studies. On the other hand, mobile C-arms, an advanced form of fluoroscopic imaging, are designed for enhanced flexibility and ease of use in operating rooms, emergency departments, and outpatient settings. Their C-shaped arm enables multi-angle imaging, improving visualization for surgeries and minimally invasive procedures.

The market is experiencing rapid growth, driven by the increasing demand for minimally invasive procedures and the rising prevalence of orthopedic, cardiovascular, and pain management interventions. Technological advancements, including AI-driven imaging enhancements, augmented reality (AR) navigation, and workflow automation, are significantly improving imaging accuracy and surgical efficiency. Moreover, increasing healthcare investments, regulatory approvals, and a growing burden of cardiovascular diseases are further accelerating market expansion.

• For instance, in April 2023, the World Heart Report revealed that over half a billion people globally are affected by cardiovascular diseases (CVD). This rising burden has fueled the demand for advanced imaging technologies like fluoroscopy and mobile C-arms, which play a crucial role in diagnosing and treating heart conditions.

As chronic diseases continue to rise worldwide, the need for cutting-edge imaging solutions is expected to surge. The fluoroscopy and mobile C-arms market is poised for substantial growth, driving innovations that enhance surgical precision, improve patient outcomes, and expand the reach of image-guided procedures.

Latest Market Trends

Rising demand for miniature and portable mobile C-arm

The growing demand for compact and portable mobile C-arms is driven by the need for enhanced mobility, space efficiency, and seamless workflow integration in surgical and clinical settings. These smaller systems provide high-precision imaging at the point of care, enabling faster diagnostics, lower radiation exposure, and improved patient comfort.

• For instance, in March 2025, Orthoscan launched VERSA, a portable mini C-arm with 180° rotation, touchscreen operation, and a lightweight 35-pound design, at AAOS 2025. This technology improves point-of-care imaging, enabling quicker diagnoses and minimizing the need for off-site imaging.

As healthcare facilities prioritize flexibility and efficiency, the adoption of miniaturized, high-precision imaging solutions continues to drive market expansion.

Increasing technological advancement in fluoroscopy and mobile C-arms

The global fluoroscopy and mobile C-arms market is witnessing rapid technological evolution, including advancements such as low-dose imaging, wireless connectivity, and AI-powered automation. These innovations enhance image quality, optimize workflows, and improve patient safety, creating a new trend for market growth.

• For instance, in July 2022, Fujifilm introduced FDR Cross, the world's first wireless, battery-powered dual-function fluoroscopy and digital radiography system. With up to eight hours of battery operation and a design 150 pounds lighter than conventional C-arms, it offers enhanced portability and workflow efficiency in ambulatory surgery centers and hospitals.

These innovations align with the industry's shift toward more sophisticated, user-friendly imaging systems, fueling continued market growth.

Fluoroscopy and Mobile C-Arms Market Growth Factors

Rising regulatory approvals

Increasing regulatory clearances for fluoroscopy and mobile C-arms are propelling market growth by ensuring compliance with safety and performance standards. Approvals from regulatory bodies such as the FDA and CE Mark validate the effectiveness of new imaging solutions, facilitating their adoption in hospitals and surgical facilities.

• For instance, in March 2024, Siemens Healthineers received FDA clearance for CIARTIC Move, the first self-driving mobile C-arm. This technology improves intraoperative efficiency, reducing surgical time by up to 50% in spine procedures and 55% in pelvic procedures while addressing staff shortages.

These regulatory milestones accelerate the availability of cutting-edge imaging solutions, enhancing workflow efficiency and improving patient outcomes.

Market Restraining Factors

High maintenance and equipment costs

The high initial investment and ongoing maintenance costs of fluoroscopy and mobile C-arm systems pose significant challenges for healthcare facilities, particularly smaller hospitals and outpatient centers. These systems require substantial capital, with expenses extending beyond procurement to include routine servicing, software updates, and calibration to maintain imaging accuracy and safety compliance.

Moreover, the integration of advanced features such as AI-powered imaging, 3D visualization, and low-dose radiation technology further escalates costs. Financial constraints can limit the adoption of cutting-edge systems, hindering market growth and restricting access to the latest imaging solutions in resource-limited settings.

Market Opportunity

Integration of AI in mobile C-arm systems

The incorporation of artificial intelligence (AI) into mobile C-arm systems is revolutionizing imaging precision, streamlining workflow automation, and minimizing the need for manual adjustments. AI-powered functionalities enhance image acquisition, lower radiation exposure, and deliver real-time feedback, ultimately improving surgical accuracy and efficiency.

• For instance, in September 2023, Philips introduced the Zenition 30, an AI-enhanced mobile C-arm designed to optimize imaging quality while reducing reliance on technician intervention during minimally invasive procedures.

As AI-driven automation continues to advance medical imaging, its integration into mobile C-arms presents a substantial opportunity for market expansion, enhancing both procedural outcomes and operational efficiency.

Regional Insights

North America: Dominant region with 39.5% market share

North America dominates the global fluoroscopy and mobile C-arms market due to high healthcare spending, advanced medical infrastructure, and widespread adoption of minimally invasive procedures. The region benefits from favorable reimbursement policies, a strong presence of key market players, and high regulatory approval rates from agencies like the FDA. Moreover, the rising incidence of chronic diseases, including cardiovascular and orthopedic disorders, is driving demand for real-time imaging solutions.

• For instance, in February 2024, the Heart Failure Society of America reported that 6.7 million U.S. adults have heart failure, with cases expected to rise to 8.5 million by 2030. This growing burden of cardiac conditions is accelerating the need for advanced imaging technologies, solidifying North America's market leadership.

Asia Pacific: Fastest growing region with the highest market CAGR

Asia-Pacific is projected to experience the highest CAGR, driven by a rising prevalence of cardiovascular diseases, rapid healthcare infrastructure development, and increasing medical tourism. Countries like China, India, and Japan are investing in advanced imaging technologies, while government initiatives and growing healthcare spending further boost market expansion. For instance, in April 2023, Fujifilm's FUJIFILM DR CALNEO CROSS, a mobile X-ray fluoroscopy unit, won the Red Dot Best of the Best Design Award for its innovation in surgical imaging.

Countries Insights

• U.S.– The U.S. leads the fluoroscopy and mobile C-arms market due to rapid technological advancements and high adoption of innovative imaging solutions. In September 2024, California’s Tahoe Forest Health System became the first U.S. hospital to install Siemens Healthineers' Ciartic Move, a fully motorized autonomous C-arm. This system enhances 2D fluoroscopy and 3D imaging, cutting spine surgery time by 50% and addressing staff shortages, driving market demand.
• Germany– Germany ranks among Europe’s top fluoroscopy and mobile C-arm markets, driven by technological advancements and major industry players. In November 2023, Ziehm Imaging expanded its Ziehm Solo FD product line with a 31 cm x 31 cm IGZO flat-panel detector, improving orthopedic imaging, including full hip scans. Such advancements strengthen Germany’s position in fluoroscopy and mobile C-arms, enhancing imaging precision and clinical efficiency.
• China – China’s fluoroscopy and mobile C-arms market is growing rapidly due to strong R&D and innovation in medical imaging. For instance, in October 2024, Perlove Medical launched China's first self-developed high-power 3D C-arm, featuring 25 kW power and 0.7mm positioning accuracy. Integrated with a robotic surgical arm and navigation planning cart, this system enhances orthopedic and spinal surgeries, reducing trauma and operation time, and driving market expansion in China.
• India – India is witnessing rapid fluoroscopy and mobile C-arm market growth due to increasing demand for advanced imaging in surgical procedures. For instance, in February 2024, Royal Philips introduced the Zenition 90 Motorized C-arm in India, designed for complex vascular and cardiac interventions. With automated workflows and advanced mobile C-arm technology, this system enhances surgical efficiency, improving access to high-quality imaging solutions and fueling market expansion.
• Saudi Arabia – Saudi Arabia’s fluoroscopy and mobile C-arms market is expanding due to increasing demand for minimally invasive procedures and government-led healthcare advancements. For instance, in October 2023, Philips unveiled the Zenition 10 C-arm at the Global Health Exhibition in Saudi Arabia, enhancing surgical accuracy and workflow optimization. This aligns with Vision 2030’s healthcare transformation, improving access to advanced radiology infrastructure and boosting the country's fluoroscopy and mobile C-arm adoption.

Segmentation Analysis

By Device Type

The mobile C-arms segment leads the global market due to its versatility, portability, and ability to provide high-resolution real-time imaging for surgical and interventional procedures. Its widespread adoption in orthopedic, cardiovascular, and trauma surgeries, coupled with advancements in AI integration and low-dose imaging technology, is fueling market growth. Moreover, the increasing preference for minimally invasive procedures and the mobility of these systems across various clinical settings further strengthen the dominance of mobile C-arms.

By Application

The cardiology segment dominates the market for fluoroscopy and mobile C-arms due to the rising prevalence of cardiovascular diseases and the growing demand for real-time imaging in interventional procedures such as angioplasty and stent implantation. The adoption of mobile C-arms for minimally invasive cardiac interventions is increasing, supported by technological innovations that enhance imaging accuracy and reduce radiation exposure. For instance, in June 2024, Royal Philips received FDA 510(k) clearance for the Zenition 90 Motorized, designed to improve efficiency in complex vascular and cardiac procedures.

By End-User

Hospitals hold the largest global market share due to their high patient volumes, demand for advanced imaging technology, and increasing reliance on minimally invasive procedures. These institutions perform a broad spectrum of surgeries, including cardiovascular, orthopedic, neurological, and oncology interventions, requiring real-time imaging for precision. With larger budgets for acquiring and maintaining cutting-edge equipment, hospitals are integrating mobile C-arms into hybrid operating rooms, further driven by the growing adoption of robot-assisted and image-guided procedures.

Company Market Share

Leading market players focus on strategic collaborations, regulatory approvals, acquisitions, and innovative product launches to enhance their market presence. By expanding their portfolios with advanced imaging solutions, these companies aim to meet the growing clinical demand for high-precision, real-time imaging. Continuous investment in research and development, along with technological advancements such as AI integration and low-dose imaging, further strengthens their competitive positioning.

Augmedics: An emerging player in the global fluoroscopy and mobile C-arms market

Augmedics is a U.S.-based medical technology company specializing in AR surgical navigation. The company focuses on revolutionizing spine and orthopedic surgeries by enhancing precision, reducing radiation exposure, and improving patient outcomes. Its cutting-edge AR solutions provide surgeons with real-time 3D visualization of anatomical structures, eliminating the need for traditional fluoroscopy and streamlining complex procedures.

Recent developments by Augmedics:

• In November 2024, Augmedics received FDA 510(k) clearance for its CT-Fluoro registration within the xvision Spine System, which eliminates the use of 3D intraoperative imaging. The initial surgery using this method was successfully performed at Rush University Medical Center. With 8,500+ patients treated and 45,000 pedicle screws implanted, this breakthrough improves fluoroscopy-based navigation, opening up more access to AR-guided spine surgeries.

Recent Developments

• November 2024 – GE HealthCare launched new clinical uses for its OEC 3D mobile CBCT C-arm, improving visualization during bronchoscopy procedures. The OEC 3D Lung Suite combines augmented fluoroscopy and motorized 3D scanning, enhancing accuracy in pulmonary interventions. The innovation makes the fluoroscopy and mobile C-arms market more robust by extending advanced intraoperative imaging capabilities across specialties.

Analyst Opinion

As per our analysts, the global fluoroscopy and mobile C-arms market is poised for substantial growth, driven by rapid technological advancements, the rising demand for minimally invasive procedures, and the increasing prevalence of orthopedic and cardiovascular disorders. Innovations such as AI integration, AR navigation, and automation are enhancing imaging precision, streamlining workflows, and improving surgical outcomes.

Despite these growth drivers, the market faces challenges such as high equipment costs, strict regulatory requirements, and the need for skilled professionals. However, ongoing research and development, increasing healthcare investments, and expanding adoption of fluoroscopy and mobile C-arms in emerging economies are expected to mitigate these challenges.

Moreover, the rising demand for image-guided interventions to improve surgical precision and patient care continues to drive the market forward, ensuring sustained growth.